{
    "nct_id": "NCT01774019",
    "official_title": "Randomized Multi-Center Study Comparing No Drainage to Preoperative Biliary Drainage Using Metal Stents in Patients With Resectable Pancreatic or Periampullary Cancer",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Age 18 or older\n* Willing and able to comply with the study procedures and provide written informed consent to participate in the study\n* Diagnosis of probable pancreatic cancer, distal common bile duct (CBD) cholangiocarcinoma and other periampullary cancers (histology not required)\n* Biliary obstructive symptoms or signs\n* Bilirubin level at/above 100 umol per liter (5.8 mg/dL)\n* Distal biliary obstruction consistent with pancreatic cancer, distal CBD cholangiocarcinoma or other periampullary malignancy\n* Location of distal biliary obstruction is such that it would allow the proximal end of a stent to be positioned at least 2cm from the hilum\n* Patients deemed as resectable by pancreatic protocol CT or MRI\n* Surgical candidate per pancreatobiliary surgeon after multi-disciplinary discussion\n* Surgery intent within 4 weeks\n* Endoscopic and surgical treatment to be provided by same team\n\nExclusion Criteria:\n\n* Biliary strictures caused by confirmed benign tumors\n* Biliary strictures caused by malignancies other than pancreatic cancer, distal CBD cholangiocarcinoma and other periampullary cancers\n* Surgically altered biliary tract anatomy, not including prior cholecystectomy\n* Neoadjuvant chemotherapy for current malignancy\n* Palliative indication due to reasons other than surgical candidate status\n* Previous biliary drainage by ERCP/PTC\n* Patients for whom endoscopic techniques are contraindicated\n* Participation in another investigational trial within 90 days\n* Pregnancy\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Age 18 or older\n* Willing and able to comply with the study procedures and provide written informed consent to participate in the study\n* Diagnosis of probable pancreatic cancer, distal common bile duct (CBD) cholangiocarcinoma and other periampullary cancers (histology not required)\n* Biliary obstructive symptoms or signs\n* Bilirubin level at/above 100 umol per liter (5.8 mg/dL)\n* Distal biliary obstruction consistent with pancreatic cancer, distal CBD cholangiocarcinoma or other periampullary malignancy\n* Location of distal biliary obstruction is such that it would allow the proximal end of a stent to be positioned at least 2cm from the hilum\n* Patients deemed as resectable by pancreatic protocol CT or MRI\n* Surgical candidate per pancreatobiliary surgeon after multi-disciplinary discussion\n* Surgery intent within 4 weeks\n* Endoscopic and surgical treatment to be provided by same team",
        "exclusion": "* Biliary strictures caused by confirmed benign tumors\n* Biliary strictures caused by malignancies other than pancreatic cancer, distal CBD cholangiocarcinoma and other periampullary cancers\n* Surgically altered biliary tract anatomy, not including prior cholecystectomy\n* Neoadjuvant chemotherapy for current malignancy\n* Palliative indication due to reasons other than surgical candidate status\n* Previous biliary drainage by ERCP/PTC\n* Patients for whom endoscopic techniques are contraindicated\n* Participation in another investigational trial within 90 days\n* Pregnancy"
    }
}